Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC

Authors

Vincent K Lam
Shirish M. Gadgeel, Henry Ford HealthFollow

Recommended Citation

Lam VK, and Gadgeel SM. Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC. J Thorac Oncol 2025; 20(2):150-153.

Document Type

Article

Publication Date

2-1-2025

Publication Title

J Thorac Oncol

PubMed ID

39914918

Volume

20

Issue

2

First Page

150

Last Page

153